Alfonso Zulueta

Board Member Appointed Feb 2022

Mr. Zulueta was President of International for Eli Lilly and Company (“Lilly”), where he was responsible for all geographies outside of the United States and Canada, from 2017 until his retirement at the end of 2021. He also served as an Executive Committee Member and Corporate Officer. His other key senior roles at Lilly included President of Global Oncology and Critical Care, Vice President of Global Marketing, and President of both Lilly Japan and Emerging Markets.

Mr. Zulueta received a bachelor’s degree in economics from DeSalle University in the Philippines and a master’s degree in business administration from the University of Virginia’s Darden School of Business. He was a board director of the European Federation of Pharmaceutical Industries and Association (EFPIA). He currently serves on the board of directors of CTS Corporation and Syneos Health.